Evidence of Liver Transplantation Clinical Trial
The aim of this study is the safety and efficacy of cryosurgery plus natural killer(NK) immunotherapy to tumors in transplanted liver.
By enrolling patients with tumors in transplanted liver adapted to enrolled criteria, this
study will document for the first time the safety and the short and long term efficacy of the
combined therapy using cryosurgery and NK cells.
The safety will be evaluated by statistics of adverse reactions. The efficacy will be
evaluated according to local relief degree, progress free survival (PFS) and overall survival
(OS).
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02239991 -
Management of Perioperative Coagulopathy With Thromboelastometry (ROTEM) in Liver Transplant
|
N/A | |
Recruiting |
NCT03013634 -
Protective Effects of Dexmedetomidine on Myocardial Injury During Liver Transplantation
|
N/A | |
Active, not recruiting |
NCT02579408 -
Quantifying Steatosis in Liver Transplant Donors
|
||
Completed |
NCT02008097 -
Clinical Benefits of B-Flow Ultrasound
|
N/A | |
Completed |
NCT04763096 -
Evaluate the Efficacy and Safety of the ADVAGRAF®
|
Phase 4 | |
Recruiting |
NCT01766518 -
The Study to Evaluate Efficacy and Safety of MY-REPT Capsule in Primary, Liver Transplantation Recipients (MYLT1)
|
Phase 4 | |
Recruiting |
NCT01607788 -
Prospective Liver Tumor (ProLiT) Database
|
N/A | |
Not yet recruiting |
NCT01860716 -
Impact of Melatonin in the Pretreatment of Organ Donor and the Influence in the Evolution of Liver Transplant.
|
Phase 3 | |
Completed |
NCT01022476 -
Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients
|
Phase 1/Phase 2 | |
Completed |
NCT01546064 -
Study to Establish Whether the Use of T-Tube in Bile Duct Anastomosis in Liver Transplantation Decreases Morbidity
|
N/A | |
Terminated |
NCT00473824 -
Randomized Phase II Study of Hepatitis C Immune Globulin Intravenous (Human), Civacir(TM), in Liver Transplantation
|
Phase 2 | |
Completed |
NCT02263703 -
Immunogenicity of HPV Vaccine in Immunosuppressed Children
|
Phase 3 | |
Terminated |
NCT00151632 -
Reduction of Tacrolimus Dose in Association With Mycophenolate Mofetil After Liver Transplantation
|
Phase 3 | |
Active, not recruiting |
NCT02350218 -
Safety, Efficacy of Eglandin® in Living Donor Liver Transplanted Patient (PROVISION)
|
Phase 2 | |
Completed |
NCT02608606 -
Determining Equivalence Dose for Oral Versus Sublingual Administration of Tacrolimus in Hepatic Receptors
|
N/A | |
Recruiting |
NCT02451046 -
Usefulness of Alpha-GST in Liver Transplantation
|
N/A | |
Completed |
NCT00177931 -
Cefepime Pharmacokinetics in Liver Transplant Recipients in an Intensive Care Unit
|
N/A | |
Completed |
NCT01147380 -
Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation
|
Phase 1 | |
Terminated |
NCT00694408 -
A Pilot Trial of Pediatric Liver Transplantation Without Steroids
|
Phase 3 | |
Terminated |
NCT00375895 -
Switch From Tacrolimus to Cyclosporin in the Treatment of Recurrent Hepatitis C After Liver Transplantation
|
Phase 3 |